C07D 207/337
Radicals substituted by carbon atoms having three bonds to hetero atoms with
Official title: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D207/337 (Radicals substituted by carbon atoms having three bonds to hetero atoms with) appears on 306 US grants and 218 published applications in this corpus.
Search patents in C07D- Granted patents
- 306
- Published applications
- 218
- Assignees
- 208
- Inventors
- 928
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 2 | 0 |
| 1978 | 6 | 0 |
| 1979 | 3 | 0 |
| 1980 | 6 | 0 |
| 1981 | 10 | 0 |
| 1982 | 2 | 0 |
| 1983 | 4 | 0 |
| 1984 | 4 | 0 |
| 1985 | 4 | 0 |
| 1986 | 6 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 11 | 0 |
| 1990 | 6 | 0 |
| 1991 | 8 | 0 |
| 1992 | 6 | 0 |
| 1993 | 14 | 0 |
| 1994 | 6 | 0 |
| 1995 | 5 | 0 |
| 1996 | 6 | 0 |
| 1997 | 4 | 0 |
| 1998 | 5 | 0 |
| 1999 | 7 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 0 |
| 2002 | 6 | 3 |
| 2003 | 3 | 5 |
| 2004 | 3 | 8 |
| 2005 | 3 | 11 |
| 2006 | 4 | 9 |
| 2007 | 3 | 7 |
| 2008 | 5 | 8 |
| 2009 | 6 | 6 |
| 2010 | 4 | 6 |
| 2011 | 6 | 19 |
| 2012 | 1 | 3 |
| 2013 | 13 | 13 |
| 2014 | 11 | 17 |
| 2015 | 10 | 10 |
| 2016 | 10 | 15 |
| 2017 | 12 | 8 |
| 2018 | 7 | 11 |
| 2019 | 6 | 4 |
| 2020 | 10 | 18 |
| 2021 | 12 | 8 |
| 2022 | 4 | 8 |
| 2023 | 6 | 11 |
| 2024 | 5 | 4 |
| 2025 | 4 | 3 |
| 2026 | 5 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compound and method for preventing or treating of respiratory diseases comprising the same as an active ingredient28 Jul 2026US 12,691,101 B2Yonsei University, University—Industry Foundation (Uif)
- Pharmaceutical salt of an arylpyrrole derivative26 May 2026US 12,637,424 B2Sentinel Oncology Limited
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Epitope-based approach for allergy treatments and inhibitors for Crohn's disease17 Mar 2026US 12,576,123 B2Psomagen, Inc.
- Glutamine analogs17 Mar 2026US 12,577,201 B2Jacobio Pharmaceuticals Co., Ltd.
- Ophthalmic lens comprising an acrylonitrile compound24 Sep 2026US 2026/0286135 A1Essilor International
- Process for producing pyrrole compound9 Jul 2026US 2026/0193181 A1Takeda Pharmaceutical Company Limited
- Monomer, polymer, chemically amplified resist composition, and pattern forming process25 Jun 2026US 2026/0176235 A1Shin-Etsu Chemical Co., Ltd.
- Heteroaromatic inhibitors of astacin proteinases25 Dec 2025US 2025/0388544 A1Vivoryon Therapeutics N.V.
- Bismuthene as versatile photocatalyst operating under variable conditions for photoredox c-h bond functionalization13 Nov 2025US 2025/0345777 A1Koc Universitesi
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Retinoid-like heterocycles74US 5,559,248 ABristol-Myers Squibb Company · 1996
- Biaryl compounds as serine protease inhibitors57US 6,699,994 B1BioCryst Pharmaceuticals, Inc. · 2004
- Heterocyclic inhibitors of ERK2 and uses thereof55US 7,304,061 B2Vertex Pharmaceuticals Incorporated · 2007
- Heterocyclic inhibitors of ERK2 and uses thereof52US 7,345,054 B2Vertex Pharmaceuticals Incorporated · 2008